Whereas the impact of GCS inhibition on the immune response remains to be evaluated, it is tempting to speculate that targeting the GCS could prevent melanoma cell dedifferentiation, contributing to enhancing immune response against melanoma cells. The gene discussed is UGCG; the disease is melanoma.